The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Asthenopia 5
SANDOSTATIN LAR DEPOT Asthma 5
SANDOSTATIN LAR DEPOT Blindness unilateral 5
SANDOSTATIN LAR DEPOT Blister 5
SANDOSTATIN LAR DEPOT Blood cholesterol decreased 5
SANDOSTATIN LAR DEPOT Bursitis 5
SANDOSTATIN LAR DEPOT Chronic obstructive pulmonary disease 5
SANDOSTATIN LAR DEPOT Cold sweat 5
SANDOSTATIN LAR DEPOT Communication disorder 5
SANDOSTATIN LAR DEPOT Daydreaming 5
SANDOSTATIN LAR DEPOT Dental caries 5
SANDOSTATIN LAR DEPOT Device issue 5
SANDOSTATIN LAR DEPOT Device occlusion 5
SANDOSTATIN LAR DEPOT Disturbance in attention 5
SANDOSTATIN LAR DEPOT Drug effect decreased 5
SANDOSTATIN LAR DEPOT Drug intolerance 5
SANDOSTATIN LAR DEPOT Duodenal obstruction 5
SANDOSTATIN LAR DEPOT Dysbacteriosis 5
SANDOSTATIN LAR DEPOT Dysentery 5
SANDOSTATIN LAR DEPOT Electrolyte imbalance 5

Total Records: 2,045     Number of Pages: 103